Fred Aslan, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Artiva Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARTV alertsAbout Fred Aslan, M.D.
Fred Aslan, M.D. is recorded as CFO at Artiva Biotherapeutics, Inc. (ARTV) since May 18, 2026. Artiva Biotherapeutics, Inc. reported in an 8-K filed May 19, 2026 that Fred Aslan, M.D. was appointed principal financial officer and principal accounting officer, effective May 18, 2026. Artiva Biotherapeutics, Inc. reported in an 8-K filed May 19, 2026 that Fred Aslan, M.D. resigned as President, effective May 18, 2026. Artiva Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Artiva Biotherapeutics, Inc. includes Fred Aslan (CEO and Board Member), Neha Krishnamohan (CFO), Thad Huston (CFO) and 7 others.
“On the Effective Date, the Company appointed (i) Dr. Aslan as the Company's principal financial officer and principal accounting officer and (ii) Dr. Miralles as the Company's President and Head of Research and Development.”
“On May 18, 2026 (the "Effective Date"), Fred Aslan, M.D. resigned as President of the Company in connection with Dr. Miralles's appointment as President and Head of Research and Development of the Company as described below.”
Affiliation history
-
Current
2026-05-18–present
-
2026-05-18–2026-05-18
Company network
Leadership on record at Artiva Biotherapeutics, Inc.
- Fred Aslan CEO, Board Member
- Neha Krishnamohan CFO
- Thad Huston CFO
- Jennifer Bush COO
- Alison Moore, Ph.D. Board Member
- Brian Daniels, M.D. Board Member
- Daniel Baker Board Member
- Daniel Baker, Ph.D. Board Member
- Elaine Sorg Board Member
- Laura Stoppel, Ph.D. Board Member